About Jeremy Ryan
Posts by Jeremy Ryan:
Pfizer (PFE) looks like a good opportunity at the current price. While they do face some serious risks to future profits due to increased generic competition, they have great economies of scale, potential for new drugs, in addition to serious power within their industry and with public officials which should result in them keeping their lead above competition in the long run.
The market has overreacted to just how serious their current threats are and Pfizer also pays a good dividend while you wait for the market to correct.
I initiated a position today.